783 related articles for article (PubMed ID: 26830780)
1. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
2. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
3. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
4. [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
Mücke M; Carter C; Cuhls H; Prüß M; Radbruch L; Häuser W
Schmerz; 2016 Feb; 30(1):25-36. PubMed ID: 26809975
[TBL] [Abstract][Full Text] [Related]
5. [Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Sommer C; Welsch P; Klose P; Schaefert R; Petzke F; Häuser W
Schmerz; 2015 Feb; 29(1):35-46. PubMed ID: 25376548
[TBL] [Abstract][Full Text] [Related]
6. [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Petzke F; Welsch P; Klose P; Schaefert R; Sommer C; Häuser W
Schmerz; 2015 Feb; 29(1):60-72. PubMed ID: 25503883
[TBL] [Abstract][Full Text] [Related]
7. [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Schaefert R; Welsch P; Klose P; Sommer C; Petzke F; Häuser W
Schmerz; 2015 Feb; 29(1):47-59. PubMed ID: 25376547
[TBL] [Abstract][Full Text] [Related]
8. Cannabis-based medicines and medical cannabis for adults with cancer pain.
Häuser W; Welsch P; Radbruch L; Fisher E; Bell RF; Moore RA
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014915. PubMed ID: 37283486
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids for fibromyalgia.
Walitt B; Klose P; Fitzcharles MA; Phillips T; Häuser W
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011694. PubMed ID: 27428009
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.
Häuser W; Welsch P; Klose P; Radbruch L; Fitzcharles MA
Schmerz; 2019 Oct; 33(5):424-436. PubMed ID: 31073761
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.
Fitzcharles MA; Baerwald C; Ablin J; Häuser W
Schmerz; 2016 Feb; 30(1):47-61. PubMed ID: 26767993
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
Boychuk DG; Goddard G; Mauro G; Orellana MF
J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955
[TBL] [Abstract][Full Text] [Related]
13. Opioids for neuropathic pain.
McNicol ED; Midbari A; Eisenberg E
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD006146. PubMed ID: 23986501
[TBL] [Abstract][Full Text] [Related]
14. Oxycodone for neuropathic pain and fibromyalgia in adults.
Gaskell H; Moore RA; Derry S; Stannard C
Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
[TBL] [Abstract][Full Text] [Related]
15. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture for neuropathic pain in adults.
Ju ZY; Wang K; Cui HS; Yao Y; Liu SM; Zhou J; Chen TY; Xia J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012057. PubMed ID: 29197180
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Aviram J; Samuelly-Leichtag G
Pain Physician; 2017 Sep; 20(6):E755-E796. PubMed ID: 28934780
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
Volz MS; Siegmund B; Häuser W
Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
[TBL] [Abstract][Full Text] [Related]
19. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
20. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
